share_log

Choice Hotels International And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via news ·  May 28, 2023 11:23

(VIANEWS) – Choice Hotels International (CHH), Antero Midstream Partners LP (AM), PACCAR (PCAR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Choice Hotels International (CHH)

18.3% sales growth and 175.63% return on equity

Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor worldwide. The company operates in Hotel Franchising and Corporate & Other segments. It franchises lodging properties under the brand names of Comfort Inn, Comfort Suites, Quality, Clarion, Clarion Pointe, Sleep Inn, Econo Lodge, Rodeway Inn, MainStay Suites, Suburban Extended Stay Hotel, WoodSpring Suites, Everhome Suites, Cambria Hotels, and Ascend Hotel Collection. The company also develops and markets cloud-based property management software to non-franchised hoteliers. As of December 31, 2020, it had 7,147 hotels with 597,977 rooms located in 50 states, the District of Columbia and approximately 40 countries and territories. The company was founded in 1939 and is based in Rockville, Maryland.

Earnings Per Share

As for profitability, Choice Hotels International has a trailing twelve months EPS of $5.77.

PE Ratio

Choice Hotels International has a trailing twelve months price to earnings ratio of 20.94. Meaning, the purchaser of the share is investing $20.94 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 175.63%.

Yearly Top and Bottom Value

Choice Hotels International's stock is valued at $120.82 at 11:22 EST, under its 52-week high of $133.13 and way above its 52-week low of $104.15.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 1.15 and the estimated forward annual dividend yield is 0.94%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 18.2% and 22.4%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Choice Hotels International's EBITDA is 5.17.

2. Antero Midstream Partners LP (AM)

17.6% sales growth and 15% return on equity

Antero Midstream Corporation owns and operates midstream energy assets. It owns and operates natural gas gathering pipelines, compression stations, processing and fractionation plants, and water handling and treatment assets in the Marcellus Shale and Utica Shale basins. The company was founded in 2013 and is headquartered in Denver, Colorado.

Earnings Per Share

As for profitability, Antero Midstream Partners LP has a trailing twelve months EPS of $0.69.

PE Ratio

Antero Midstream Partners LP has a trailing twelve months price to earnings ratio of 15.35. Meaning, the purchaser of the share is investing $15.35 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15%.

Sales Growth

Antero Midstream Partners LP's sales growth is 15.3% for the current quarter and 17.6% for the next.

3. PACCAR (PCAR)

14.1% sales growth and 24.17% return on equity

PACCAR Inc designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks in the United States, Europe, Mexico, South America, Australia, and internationally. It operates through three segments: Truck, Parts, and Financial Services. The Truck segment designs, manufactures, and distributes trucks for the over-the-road and off-highway hauling of commercial and consumer goods. It sells its trucks through a network of independent dealers under the Kenworth, Peterbilt, and DAF nameplates. The Parts segment distributes aftermarket parts for trucks and related commercial vehicles. The Financial Services segment conducts full-service leasing operations under the PacLease trade name, as well as provides finance and leasing products and services to customers and dealers. This segment also offers equipment financing and administrative support services for its franchisees; retail loan and leasing services for small, medium, and large commercial trucking companies, as well as independent owners/operators and other businesses; and truck inventory financing services to independent dealers. In addition, this segment offers loans and leases directly to customers for the acquisition of trucks and related equipment. The company also manufactures and markets industrial winches under the Braden, Carco, and Gearmatic nameplates. PACCAR Inc was founded in 1905 and is headquartered in Bellevue, Washington.

Earnings Per Share

As for profitability, PACCAR has a trailing twelve months EPS of $6.

PE Ratio

PACCAR has a trailing twelve months price to earnings ratio of 11.9. Meaning, the purchaser of the share is investing $11.9 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.17%.

4. Aercap Holdings N.V. Ordinary Shares (AER)

11.9% sales growth and 11.12% return on equity

AerCap Holdings N.V., an aircraft leasing company, engages in the lease, financing, sale, and management of commercial aircraft and engines in China, the United States, Ireland, and internationally. The company offers aircraft asset management services, including remarketing aircraft; collecting rental and maintenance rent payments, monitoring aircraft maintenance, monitoring and enforcing contract compliance, and accepting delivery and redelivery of aircraft; and conducting ongoing lessee financial performance reviews. Its aircraft asset management services also comprise periodically inspecting the leased aircraft; coordinating technical modifications to aircraft to meet new lessee requirements; conducting restructuring negotiations in connection with lease defaults; repossessing aircraft; arranging and monitoring insurance coverage; registering and de-registering aircraft; arranging for aircraft and aircraft engine valuations; and providing market research services. The company also provides cash management services, including treasury services, such as the financing, refinancing, hedging, and ongoing cash management of vehicles; and administrative services comprising accounting and corporate secretarial services consisting of the preparation of budgets and financial statements. As of December 31, 2018, it had a portfolio of 1,421 owned, managed, or on order aircraft. AerCap Holdings N.V. was founded in 1995 and is headquartered in Dublin, Ireland.

Earnings Per Share

As for profitability, Aercap Holdings N.V. Ordinary Shares has a trailing twelve months EPS of $7.29.

PE Ratio

Aercap Holdings N.V. Ordinary Shares has a trailing twelve months price to earnings ratio of 8.12. Meaning, the purchaser of the share is investing $8.12 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.12%.

Volume

Today's last reported volume for Aercap Holdings N.V. Ordinary Shares is 668116 which is 55.43% below its average volume of 1499230.

5. Masimo Corporation (MASI)

10.3% sales growth and 8.12% return on equity

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.

Earnings Per Share

As for profitability, Masimo Corporation has a trailing twelve months EPS of $2.17.

PE Ratio

Masimo Corporation has a trailing twelve months price to earnings ratio of 72.51. Meaning, the purchaser of the share is investing $72.51 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.12%.

Sales Growth

Masimo Corporation's sales growth is negative 2.2% for the current quarter and 10.3% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 85.7%, now sitting on 2.3B for the twelve trailing months.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter is a negative 29.6% and positive 25% for the next.

Volume

Today's last reported volume for Masimo Corporation is 366439 which is 3.05% below its average volume of 378001.

6. Apollo Medical Holdings (AMEH)

9.3% sales growth and 9.51% return on equity

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Earnings Per Share

As for profitability, Apollo Medical Holdings has a trailing twelve months EPS of $1.01.

PE Ratio

Apollo Medical Holdings has a trailing twelve months price to earnings ratio of 33.17. Meaning, the purchaser of the share is investing $33.17 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.51%.

Volume

Today's last reported volume for Apollo Medical Holdings is 127781 which is 29.74% below its average volume of 181879.

Sales Growth

Apollo Medical Holdings's sales growth is 26.8% for the present quarter and 9.3% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Apollo Medical Holdings's EBITDA is 1.22.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment